Business
Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol
Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabid...
About this update from Crescita Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\nCrescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nLAVAL, QC, Oct. 15, 2018\n\n\n\nLAVAL, QC, Oct. 15, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, is pleased to announce that its patented transdermal delivery technologies: Multiplexed Molecular Penetration Enhancer (\"MMPE™\") and DuraPeel™ have demonstrated enhanced permeation of Cannabidiol (\"CBD\"), the non-psychoactive component of cannabis, in a recent in-vitro skin permeation study performed in Franz Diffusion Cells.\n\n \n \n\n \nThe study, using human cadaver skin, was performed by an independent Southern California-based laboratory specializing in the transdermal delivery of actives, showed that both MMPE and DuraPeel significantly increased the transdermal permeation of CBD over the control formulation by up to 14- and 6-fold, respectively. CBD has been associated with antiseizure, antioxidant, neuroprotective, anxiolytic, anti-inflammatory, antidepressant, and antipsychotic effects. These proprietary technologies have already been successfully utilized in a number of topical products to enhance the delivery of different active ingredients. The Company has expertise in developing and manufacturing topical and transdermal skincare products for a wide variety of conditions and is interested in engaging with partners to develop and commercialize cannabinoid-containing products. \n\"We are extremely pleased with the results of this preliminary study demonstrating the ability of Crescita's proprietary drug delivery technologies to increase the permeation of CBD through the skin.\" said Serge Verreault, President and CEO. \"With the Canadian legalization date of cannabis only days away, and the wide range of potential applications and therapeutic a...